An international team of researchers, led by Massachusetts General Hospital and Harvard Medical School, has conducted a meta-analysis revealing that women with high β-amyloid (Aβ) exhibit significantly faster tau accumulation ...
In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease, and the ...
Mar 14, 2025
0
5
A person's "bioenergetic age"—or how youthfully their cells generate energy—might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research from Weill Cornell Medicine shows.
Mar 13, 2025
0
52
For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates.
Mar 11, 2025
0
70
For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons—as a therapeutic target for Alzheimer's disease. But anti-amyloid therapies haven't made strong ...
Mar 11, 2025
0
30
The herb rosemary has long been linked with memory. "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's "Hamlet." So it is fitting that researchers would study a compound found in rosemary and sage—carnosic ...
Mar 10, 2025
0
126
Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some Alzheimer's disease patients for up to eight weeks in a preliminary trial led by UT Southwestern Medical ...
Mar 6, 2025
0
25
Researchers from The University of Texas at Arlington and the University of California–San Francisco have used a new brain-mapping technique to identify memory-related brain cells vulnerable to protein buildup, a key factor ...
Mar 6, 2025
0
8
For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain.
Mar 6, 2025
0
15
Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology. However, biomarker detection, which is now part of the diagnostic criteria, requires a lumbar puncture ...
Mar 5, 2025
0
17
